| Isoxepac Basic information |
| Product Name: | Isoxepac |
| Synonyms: | Olopatadine Impurity 3（Olopatadine USP RC C）;6,11-Dihydro-11-oxodibenzo[b,e]oxepin-2-acetic acid, 97.0%;e)oxepin-2-aceticacid,6,11-dihydro-11-oxo-dibenz(;hp549;DIBENZ[B,E]OXEPIN-2-ACETIC ACID, 6,11-DIOHYDRO-11-OXO;6,11-Hydro-11-Oxo-Dibenz[B,E]Oxepin-2-Acetic Acid;Olapatadine;11-Oxo-6,11-Dihydrobenz(b,e)oxepin-2-Acetic Acid (Isoxepac) |
| CAS: | 55453-87-7 |
| MF: | C16H12O4 |
| MW: | 268.26 |
| EINECS: | 611-268-9 |
| Product Categories: | API;Pharmaceutical intermediate;APIs Intermediate;Intermediates & Fine Chemicals;Pharmaceuticals;bc0001 |
| Mol File: | 55453-87-7.mol |
| Isoxepac Chemical Properties |
| Melting point | 130-132°C |
| Boiling point | 528.2±50.0 °C(Predicted) |
| density | 1.39 g/cm3 |
| storage temp. | Sealed in dry,Room Temperature |
| solubility | soluble in Methanol |
| pka | 4.24±0.10(Predicted) |
| form | neat |
| color | White to Light yellow to Light orange |
| Merck | 14,5237 |
| InChIKey | QFGMXJOBTNZHEL-UHFFFAOYSA-N |
| CAS DataBase Reference | 55453-87-7(CAS DataBase Reference) |
| Safety Information |
| Hazard Codes | T |
| Risk Statements | 25-62 |
| Safety Statements | 36/37-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| RTECS | HQ4110000 |
| HazardClass | 6.1 |
| PackingGroup | III |
| HS Code | 2932996560 |
| Toxicity | LD50 orally in rats: 199 mg/kg (Ueno) |
| MSDS Information |
| Isoxepac Usage And Synthesis |
| Chemical Properties | Beige Solid |
| Uses | Isoxepac is a non-steroidal anti-inflammatory with analgesic and antipyretic activity. It is more slowly absorbed and eliminated in the rat and rabbit after oral dosing than in the dog, rhesus monkey and man.It can be used to treat allergic rhinitis, urticaria, and skin diseases with itching symptoms. |
| Definition | ChEBI: Isoxepac is a dibenzooxazepine. |
| Preparation | Isoxic acid is an important intermediate in the synthesis of the new preferred anti-allergic drug, olopatadine hydrochloride, preparation method of isoxepac:(1) condensation: prepare p-hydroxyphenylaceticacid 8-12 part, phthalide 6-12 part, sodium methylate 8-12 part by weight; Dissolve with DMAC and to add said sodium methylate behind said p-hydroxyphenylaceticacid and the phthalide; Be that 0.1-10Pa is heated to 80-170 ℃ of reaction 3-10h at pressure then; Regulate the pH value to 1-5,4-(2-carboxyl benzyloxy) toluylic acid is separated out in crystallization;(2) cyclization: with Glacial acetic acid min. 99.5 dissolving step (1) gained 4-(2-carboxyl benzyloxy) toluylic acid, adding 3-52 weight part polyphosphoric acid again, is that 0.1-10Pa is heated to 30-100 ℃ of reaction 3-12h at pressure, and crystallisation by cooling gets the Isoxepac bullion then;(3) purify: behind the said Isoxepac bullion of acetic acid ethyl dissolution, refining decolouring gets the Isoxepac product.https://patents.google.com/patent/CN102838582A/en |
| Brand name | Artil(Hoechst-Roussel) . |
| Isoxepac Preparation Products And Raw materials |
| Preparation Products | Olopatadine-->6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetate,methyl ester |
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.
日本语
한국어
Français
Deutsch
España
Türkiye